Disease-free survival as the endpoint in multimodal rectal cancer trials: have we got this right?

Lancet Gastroenterol Hepatol. 2023 Nov;8(11):962-964. doi: 10.1016/S2468-1253(23)00231-5. Epub 2023 Aug 22.
No abstract available